Therapeutic Vaccination with TNF-Kinoid in TNF Antagonist-Resistant Rheumatoid Arthritis: A Phase II Randomized, Controlled Clinical Trial

• Patrick Durez,

  Affiliation Service et Pole de Rhumatologie, Cliniques Universitaires Saint-Luc, Brussels, Belgium; Institut de Recherche Experimentale et Clinique, Universite catholique de Louvain, Rheumatology, Brussels, Belgium

  ⨯
• Pierre Vandepapeliere ,

  * E-mail: pvandepapeliere@neovacs.com

  Affiliation Neovacs S.A., Paris, France

  ⨯
• Pedro Miranda,

  Affiliation Centro de Estudios Reumatológicos, Santiago de Chile, Chile

  ⨯
• Antoaneta Toncheva,

  Affiliation National Multiprofile Transport Hospital “Tzar Boris III”, Sofia, Bulgaria

  ⨯
• Alberto Berman,

  Affiliation Centro Medico Privado de Reumatologia, San Miguel de Tucuman, Argentina

  ⨯
• Tatjana Kehler,

  Affiliation Thalassotherapia Opatija, Opatija, Croatia

  ⨯
• Eugenia Mociran,

  Affiliation Emergency County Hospital “Dr Constantin Opris”, Baia Mare, Romania

  ⨯
• Bruno Fautrel,

  Affiliations UPMC, GRC 08 (EEMOIS), Institut Pierre Louis d’Epidémiologie et Santé Publique, Paris, France, AP-HP, Pitié Salpêtrière University Hospital, Dept of Rheumatology, Paris, France

  ⨯
• Xavier Mariette,

  Affiliation Université Paris-Sud, Hôpitaux Universitaires Paris-Sud, AP-HP, INSERM U1012, Le Kremlin-Bicêtre, France

  ⨯
• Olivier Dhellin,

  Affiliation Neovacs S.A., Paris, France

  ⨯
• Bernard Fanget,

  Affiliation Neovacs S.A., Paris, France

  ⨯
• Stephane Ouary,

  Affiliation Neovacs S.A., Paris, France

  ⨯
• Géraldine Grouard-Vogel,

  Affiliation Neovacs S.A., Paris, France

  ⨯
• Marie-Christophe Boissier

  Affiliations INSERM U1125, Bobigny, France, Université Paris 13, Sorbonne Paris Cité, Bobigny, France, AP-HP, Avicenne University Hospital, Department of Rheumatology, Bobigny, France

  ⨯